University of Texas's MD Anderson Cancer Center: Dietary Supplementation May Improve Antibiotic-Induced GVHD Following Stem Cell Transplants
September 30, 2022
September 30, 2022
HOUSTON, Texas, Sept. 30 (TNSjou) -- The University of Texas's MD Anderson Cancer Center issued the following news release on Sept. 29, 2022:
* * *
Preclinical study identifies specific bacterium responsible for treatment complication and underlying causes
* * *
Researchers at The University of Texas MD Anderson Cancer Center have identified a specific gut bacterium involved in the progression of graft-versus-host disease (GVHD) after anti . . .
* * *
Preclinical study identifies specific bacterium responsible for treatment complication and underlying causes
* * *
Researchers at The University of Texas MD Anderson Cancer Center have identified a specific gut bacterium involved in the progression of graft-versus-host disease (GVHD) after anti . . .